Correction to: Preclinical Evaluation and Dosimetry of [111In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1).

Cicone F Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. f.cicone@iol.it.
Denoël T Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Gnesin S Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Riggi N Experimental Pathology Service, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Irving M Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne, CH-1066, Epalinges, Switzerland.
Jakka G Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne, CH-1066, Epalinges, Switzerland.
Schaefer N Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Viertl D Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Coukos G Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, University of Lausanne, CH-1066, Epalinges, Switzerland.
Prior JO Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.